U.S. Races to Replace IV Fluid Supplies After Hurricane Helene
Posted inAmerican Hospital Assn Dialysis Diet and Nutrition Disasters and Emergencies Drugs (Pharmaceuticals) Factories and Manufacturing Florida Food and Drug Administration Health and Human Services Department Hospitals Hurricane Helene (2024) Hurricane Milton (2024) Hurricanes and Tropical Storms North Carolina Rationing and Allocation of Resources Shortages Supply Chain

U.S. Races to Replace IV Fluid Supplies After Hurricane Helene

Officials are looking to foreign sources to ease shortages of IV bags caused by Hurricane Helene as hospitals begin rationing fluids to protect the sickest patients.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
Posted inAcademic and Scientific Journals Alzheimer's Disease Cassava Sciences Inc City University of New York Clinical Trials Dementia Drugs (Pharmaceuticals) Falsification of Data Food and Drug Administration Regulation and Deregulation of Industry Securities and Commodities Violations Securities and Exchange Commission United States Wang, Hoau-Yan your-feed-science

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
F.D.A. Approves a New Antipsychotic Drug
Posted inBristol Myers Squibb Company Clinical Trials Dopamine Drugs (Pharmaceuticals) Food and Drug Administration Karuna Therapeutics Inc Psychiatry and Psychiatrists Psychology and Psychologists Regulation and Deregulation of Industry Research Schizophrenia Therapy and Rehabilitation Weight

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.